Abivax Up, Maersk Jumps, Sainsbury's Rise

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Abivax soared as much as 27% after a clinical-trial update soothed some investors’ concerns about whether cancer could be a potential side effect of the biotech’s most promising experimental drug.
- A.P. Moller-Maersk A/S shares jumped in early trading after the shipping company upgraded its profit outlook for this year, citing solid demand especially in Asia and a global container market that looks to stay healthy for the rest of the year.
- Sainsbury’s shares rise as much as 3.5%, the most in seven months, after the British retailer reported 1Q sales that were in line with consensus expectations, avoiding the underperformance of its peer Tesco. Analysts pointed to growth in groceries and Argos’ performance as signs of strength.

See omnystudio.com/listener for privacy information.